Gerstein et al., 2021)
(1)-(5), are as specified in Table 3
From liability issues to shifting insurance coverage, the landscape for healthcare providers is evolving rapidly
A prospective RCT with dual metabolic and psychiatric endpoints, enrolling patients with active depression or anxiety plus diabetes or obesity, stratified by SUD comorbidity and baseline anhedonia severity that trial is buildable, and the recruitment population is not hypothetical
L-Carnitine supplementation may cause mild gastrointestinal symptoms, including nausea, vomiting, abdominal cramps, and diarrhea
Dunning KR, Cashman K, Russell DL, Thompson JG, Norman RJ, Robker RL